Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Learn which cash rewards credit cards have no fees, allowing you to earn rewards without the financial burden. Make informed choices.
27,645 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Bitcoin has captivated investors with a bold target: 150K by year-end. This piece breaks down what that entails, how ...
Chewy rode a brighter sales outlook to a rally in its stock, with the company signaling durable demand for pet care d...
Apple launched the MacBook Neo at a budget price, signaling a potential breakthrough for Mac demand. This article bre...
Public backlash can move beyond headlines and into wallets. This in-depth look examines the financial ripple effects ...
Policy shifts around AI chips could change how Nvidia and AMD ship GPUs worldwide. This article breaks down the risks...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
When headlines talk about a stock suddenly bleeding, traders worry about customer losses and slowing growth. This art...
Retirees often face surprising tax bills even as income shrinks. This article highlights the smart move retirees make...
AI-enabled surgical robotics are turning hospitals into data hubs. Intuitive Surgical, Medtronic, and Stryker sit at ...
Stifel boosted CrowdStrike’s target to $660 ahead of the June earnings release, signaling renewed optimism on growth ...
When a senior vice president sells stock, it can spark questions about a company's direction. This guide explains wha...